Bupropion Tapering and Sertraline Initiation Strategy
For a patient on bupropion 450 mg daily, taper to 300 mg daily for at least one week, then to 150 mg daily for another week before discontinuation; initiate sertraline at 50 mg daily and titrate to 100-200 mg based on response after 2-4 weeks.
Bupropion Discontinuation Protocol
The FDA label explicitly states that when discontinuing bupropion XL 300 mg daily, you must decrease to 150 mg once daily prior to complete discontinuation 1. Since your patient is on the maximum dose of 450 mg (which exceeds the standard 300 mg target dose for MDD), a more gradual approach is warranted:
Recommended Tapering Schedule:
- Week 1-2: Reduce from 450 mg to 300 mg daily
- Week 3-4: Reduce from 300 mg to 150 mg daily
- After Week 4: Discontinue completely
This stepwise reduction minimizes seizure risk (a critical concern with bupropion) and reduces withdrawal symptoms. The gradual taper is particularly important given the patient is on a supratherapeutic dose—the FDA-approved maximum for MDD is 300 mg daily 1.
Critical Safety Consideration:
Bupropion carries seizure risk that increases with dose. The gradual taper protects against both withdrawal phenomena and seizure risk during the transition period 1.
Sertraline Initiation and Titration
Start sertraline at 50 mg daily in the morning, taken with or without food. This is the manufacturer's recommended starting dose and is the optimal dose for most patients when considering both efficacy and tolerability 2.
Timing of Initiation:
You can initiate sertraline immediately when beginning the bupropion taper—there is no required washout period between these medications. They have different mechanisms of action (bupropion affects norepinephrine/dopamine; sertraline affects serotonin) and no contraindicated interactions 3, 4.
Titration Strategy:
- Weeks 1-4: Maintain sertraline 50 mg daily while monitoring response
- Week 4-6: If inadequate response, increase to 100 mg daily
- Week 6-8: If still inadequate response, increase to 150-200 mg daily
The evidence shows that while 50 mg is effective for many patients, approximately 47-68% may require dose increases to achieve remission 5. The FDA label supports flexible dosing from 50-200 mg daily 6.
Assessment Timeline:
Evaluate therapeutic response and adverse effects within 1-2 weeks of initiation, then regularly thereafter 3. If no adequate response occurs within 6-8 weeks, consider modifying treatment 3.
Important Clinical Caveats
Withdrawal symptom differentiation: During the bupropion taper, monitor for withdrawal symptoms (irritability, mood changes, sleep disturbance). These differ from depression relapse by their temporal relationship to dose reduction and typically improve within 1-2 weeks 7, 8.
Suicidality monitoring: Both discontinuation of one antidepressant and initiation of another require close monitoring for suicidal ideation, particularly in the first 1-2 months 3, 4. SSRIs like sertraline carry FDA warnings about increased suicide risk, especially early in treatment.
If the patient has difficulty tolerating the taper: Consider slowing the reduction schedule further. Recent evidence suggests that some patients require much more gradual tapers (hyperbolic dose reductions over months) to minimize withdrawal symptoms 9, though this is more commonly needed with SSRIs than bupropion.
Sertraline dose adequacy: Don't assume 50 mg is sufficient. One-third to two-thirds of patients require higher doses for optimal response 5. The therapeutic range extends to 200 mg daily, and dose increases should occur at weekly intervals minimum 6.